Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nanotechnology|June 29, 2026
Compact Modeling of Pd-MoS2 Self-rectifying RRAM based on modulated Schottky barrier equationMin-Woo Kwon, Yoojin Shin, Dongjun Jang
The Science of the Total Environment|May 19, 2015
Tracing metal sources in core sediments of the artificial lake An-Dong, Korea: Concentration and metal associationMansik Choi, Jongkyu Park, Dongjin Cho, et al.
Science Advances|June 5, 2026
Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancersJiwon Kim, Jaeik Oh, Dongjun Jang, et al.
Experimental & Molecular Medicine|July 6, 2022
Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer typesJaeik Oh, Chanwoong Hwa, Dongjun Jang, et al.
Genes & Genomics|November 26, 2022
Gut bacteria-derived 3-phenylpropionylglycine mitigates adipocyte differentiation of 3T3-L1 cells by inhibiting adiponectin-PPAR pathwayHae Rim Jung, Yumi Oh, Dongjun Jang, et al.
Cancer Letters|October 17, 2020
Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancersYumi Oh, Hae Rim Jung, Seoyeon Min, et al.
Experimental & Molecular Medicine|August 31, 2025
Comprehensive profiling of RNA modification-related genes identifies RNA m7G binding protein CBP20 as a therapeutic target for tumor growth inhibitionYoonsung Cho, Sang Eun Lee, Jaeik Oh, et al.
Oncogene|April 13, 2021
CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancersHae Rim Jung, Yumi Oh, Deukchae Na, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 26, 2024
RNA N6-Methyladenosine-Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN-γ Signaling in Gastric CancerDongjun Jang, Chanwoong Hwa, Seoyeon Kim, et al.
Molecular Cancer|August 2, 2024
Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacyYumi Oh, Sujeong Kim, Yunjae Kim, et al.
Pageof 2